Main Content start here
Main Layout
Report Description

Report Description

Egypt Liver Cancer Therapeutics Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The rising incidence of liver cancer has been recorded as the second leading cause of death after the deaths due to cardiovascular disorders. Egypt ranks number 2 in the world in terms of deaths caused by liver cancer. According to the latest report of WHO, in 2020, liver cancer deaths in Egypt accounted for 24,512 or 4.57% of total deaths. The growing aging population that is highly prone to such chronic ailments, high consumption of alcohol, and rising number of smokers are primarily contributing to the increasing cases of liver cancer. As a result, the high prevalence of such cases is increasing the demand for liver cancer therapeutics. Liver cancer is a chronic, progressive, and life-threatening disorder that begins at the cellular level of the liver. The liver is one of the vital organs in the human body. Its function is to produce enzymes and bile, which facilitates the digestion of food. It also produces blood clotting proteins and helps in purifying the blood by flushing out harmful materials from the body.

Most of the patients do not feel or show the symptoms related to liver cancer at an early stage, but in later stages, the patient starts to feel a loss of appetite, rapid weight loss, nausea, vomiting, abdominal pain, and swelling. Early detection and availability of a wide range of liver cancer therapeutics help in preventing and treating liver cancer. Therefore, the demand for liver cancer therapeutics in Egypt is surging rapidly.

Apart from this, extensive R&D activities going on in biotechnology and medical science are providing trust to the market. Moreover, several technological advancements in cancer therapeutics, such as the introduction of gene therapy and bioartificial liver, are strengthening the market growth. Furthermore, the increasing investments by both private and government sectors to upgrade the healthcare infrastructure in Egypt are opening great growth avenues for the market players. In addition to this, the growing adoption of smartphones and penetration of high-speed internet has allowed the patients to quickly access medical facilities remotely, hence creating a positive outlook for the market. All these aforementioned factors are expected to propel the Egypt liver therapeutics market over the forecast period.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The Egypt liver cancer therapeutics market is segmented by type, by therapy, by end users, competitional landscape, and regional distribution. Based on type, the market is differentiated between hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and others. By therapy the market is bifurcated into targeted therapy, radiation therapy, immunotherapy, chemotherapy, and others. Based on end users the market is fragmented into hospitals & clinics, ambulatory care centers, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Cario, Alexandria, Giza Qalyubia, Port Said Suez, and Rest of Egypt                                   

Company Profile

Roche Egypt LLC, Bayer Middle East FZE, Eli Lilly and Company (Egypt), Merck Egypt, and Novartis Egypt, are the leading market players responsible for the growth of Egypt liver cancer therapeutics market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, volume in units, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         Therapy

·         End User

Regional scope

Cario, Alexandria, Giza Qalyubia, Port Said Suez, and Rest of Egypt

Key companies profiled

Roche Egypt LLC, Bayer Middle East FZE, Eli Lilly and Company (Egypt), Merck Egypt, and Novartis Egypt

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Egypt Liver Cancer Therapeutics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Egypt Liver Cancer Therapeutics Market, By Type:
    • Hepatocellular Carcinoma
    • Cholangiocarcinoma
    • Hepatoblastoma
    • Others.
  • Egypt Liver Cancer Therapeutics Market, By Crop Therapy:
    • Targeted Therapy
    • Radiation Therapy
    • Immunotherapy
    • Chemotherapy
    • Others
  • Egypt Liver Cancer Therapeutics Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Care Centers
    • Others
  • Egypt Liver Cancer Therapeutics Market, By Region:

o   Alexandria

o   Giza Qalyubia

o   Port Said Suez

o   Rest of Egypt 

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Egypt Liver Cancer Therapeutics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Egypt Liver Cancer Therapeutics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Egypt Liver Cancer Therapeutics Market

4.    Voice of Customer

5.    Executive Summary

6.    Clinical Trials Analysis

7.    Egypt Liver Cancer Therapeutics Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Others)

7.2.2.     By Therapy (Targeted Therapy, Radiation Therapy, Immunotherapy, Chemotherapy, Others)

7.2.3.     By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

7.2.4.     By Company (2021)

7.2.5.     By Region

7.3.  Product Market Map

8.    Egypt Hepatocellular Carcinoma Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By End User

9.    Egypt Cholangiocarcinoma Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapy

9.2.2.     By End User

10.  Egypt Hepatoblastoma Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Therapy

10.2.2.  By End User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  Egypt Economic Profile

15.  Competitive Landscape

15.1.              Roche Egypt LLC

15.2.              Bayer Middle East FZE

15.3.              Eli Lilly and Company (Egypt)

15.4.              Merck Egypt

15.5.              Novartis Egypt

16.  Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

Egypt ranks number 2 in terms of deaths caused by liver cancer. this along with the high alcohol consumption in the region is expected to propel the Egypt Liver Cancer Therapeutics Market with an impressive CAGR during the forecast period, 2023-2027.

Based on the end user, the market is segmented into hospitals & clinics, ambulatory care centers, and others. Among these hospitals and clinics are expected to dominate the market. This is primarily because, hospitals usually have fully developed infrastructure with technologically advanced medical devices and equipment required to perform the stent surgery and facilitate proper care after the surgery.

Roche Egypt LLC, Bayer Middle East FZE, Eli Lilly and Company (Egypt), Merck Egypt, and Novartis Egypt, are the leading market players responsible for the growth of Egypt liver cancer therapeutics market.

New market players may invest actively in research and innovative product development. Also, merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

Related Reports